Western Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.53M Buy
23,590
+3,338
+16% +$359K 0.15% 136
2025
Q1
$2.04M Sell
20,252
-8
-0% -$807 0.14% 153
2024
Q4
$1.81M Buy
20,260
+1,678
+9% +$150K 0.12% 163
2024
Q3
$1.56M Sell
18,582
-44
-0.2% -$3.69K 0.09% 231
2024
Q2
$1.43M Buy
18,626
+941
+5% +$72.5K 0.11% 167
2024
Q1
$1.21M Buy
17,685
+757
+4% +$51.8K 0.09% 201
2023
Q4
$979K Buy
16,928
+1,043
+7% +$60.3K 0.07% 282
2023
Q3
$839K Buy
15,885
+1,489
+10% +$78.6K 0.07% 284
2023
Q2
$779K Buy
14,396
+1,407
+11% +$76.1K 0.07% 283
2023
Q1
$650K Buy
12,989
+563
+5% +$28.2K 0.06% 313
2022
Q4
$575K Sell
12,426
-12,585
-50% -$582K 0.06% 313
2022
Q3
$973K Buy
25,011
+409
+2% +$15.9K 0.06% 312
2022
Q2
$918K Sell
24,602
-98
-0.4% -$3.66K 0.05% 322
2022
Q1
$1.09M Buy
24,700
+11,824
+92% +$524K 0.05% 321
2021
Q4
$541K Buy
+12,876
New +$541K 0.05% 308
2021
Q2
$406K Buy
9,577
+376
+4% +$15.9K 0.04% 411
2021
Q1
$356K Sell
9,201
-240
-3% -$9.29K 0.05% 369
2020
Q4
$339K Sell
9,441
-78
-0.8% -$2.8K 0.05% 326
2020
Q3
$364K Buy
9,519
+351
+4% +$13.4K 0.06% 294
2020
Q2
$322K Sell
9,168
-108
-1% -$3.79K 0.06% 300
2020
Q1
$307K Buy
9,276
+462
+5% +$15.3K 0.07% 266
2019
Q4
$399K Sell
8,814
-279
-3% -$12.6K 0.06% 266
2019
Q3
$366K Sell
9,093
-93
-1% -$3.74K 0.08% 257
2019
Q2
$393K Buy
9,186
+528
+6% +$22.6K 0.05% 261
2019
Q1
$333K Sell
8,658
-325
-4% -$12.5K 0.07% 264
2018
Q4
$319K Buy
+8,983
New +$319K 0.09% 242